Playback speed
10 seconds
ESMO Breast Cancer 2023 Results of Part B of SOLTI TOT-HER3 Window of Opportunity Trial: Patritumab Deruxtecan in HR+/HER2- & TNBC
299 views
May 31, 2023
Login to view comments.
Click here to Login